Search

The Center for Innovative Phage Applications and Therapeutics (IPATH) at UCSD has published the second issue of its quarterly newsletter. This issue describes the speaker series they hosted in 2019, which you can watch online, along with i

Hannah Hampton (University of Otago) and colleagues published a review in Nature on the arms race between bacteria and phages.

The Center for Innovative Phage Applications and Therapeutics (IPATH) at UCSD has published the second issue of its quarterly newsletter. This issue describes the speaker series they hosted in 2019, which you can watch online, along with i

Save the date for Viruses of Microbes 2020, which will be hosted in Guimarães, Portugal July 13-17, 2020. Also, students and postdocs, stay tuned: Phage Directory will be giving out travel awards!

A nice Inside Science article on the underestimated roles of viruses in chemical cycles and climate, and the research that's amassing on the subject. Phage researchers Lindsey Solden, Gary Trubl, Jennifer Brum, Martha Clokie and more are in

Adaptive Phage Therapeutics was named one of five biotech companies to watch in 2020 by BioBuzz.

The 4th Phages for Global Health workshop started this week in Tanzania! The 25 participants come from Kenya, Rwanda, Tanzania and Uganda.

PhagoMed attended the Biotech Showcase 2020 this week in San Francisco, and announced it is looking to raise $16 million from US and European investors to bring its phage products to the clinic (watch this interview with CEO Alexander Belcr

ASM Microbe will be in Chicago June 18-22, and will include a session on virocells co-hosted by Simon Roux and Matthew Sullivan!

Cristina Howard-Varona (Ohio State University) and colleagues published a new paper on phage-specific metabolic reprogramming of 'virocells' (infected cells). This work digs into the question of how phage-infected cells affect their surroun

Adaptive Phage Therapeutics was awarded a $10.2-million contract with the US Department of Defense. The funds will go toward developing PhageBank™️, the company's personalized phage therapy system, including conducting a clinical trial.

Locus Biosciences announced it has opened enrollment for a Phase 1b clinical trial evaluating a CRISPR Cas3-enhanced phage (crPhage™) product that will target E. coli causing urinary tract infections. This is the world's first controlled cl

The Phages4Cure project is a German initiative (run by the Fraunhofer ITEM at Braunschweig in partnership with the DSMZ) to develop phage cocktails to treat P. aeruginosa in the lung. Fraunhofer ITEM has been manufacturing biologics to GMP

Phages have been in the news around the world this week! Phage therapy made the cover of Maisonneuve, a quarterly Canadian magazine (subscription required), Quanta Magazine did an in-depth feature on how phage resistance evolves differently

Phages have been in the news around the world this week! Phage therapy made the cover of Maisonneuve, a quarterly Canadian magazine (subscription required), Quanta Magazine did an in-depth feature on how phage resistance evolves differently

The Phages4Cure project is a German initiative (run by the Fraunhofer ITEM at Braunschweig in partnership with the DSMZ) to develop phage cocktails to treat P. aeruginosa in the lung. Fraunhofer ITEM has been manufacturing biologics to GMP

Locus Biosciences announced it has opened enrollment for a Phase 1b clinical trial evaluating a CRISPR Cas3-enhanced phage (crPhage™) product that will target E. coli causing urinary tract infections. This is the world's first controlled cl

Adaptive Phage Therapeutics was awarded a $10.2-million contract with the US Department of Defense. The funds will go toward developing PhageBank™️, the company's personalized phage therapy system, including conducting a clinical trial.

Cristina Howard-Varona (Ohio State University) and colleagues published a new paper on phage-specific metabolic reprogramming of 'virocells' (infected cells). This work digs into the question of how phage-infected cells affect their surroun

BBC News has listed Isabelle Carnell Holdaway's phage therapy case as one of the biggest 'Man on the Moon' breakthroughs of 2019.